P4SB, SinFonia, and MIX-UP all centre on engineering Pseudomonas putida or microbial consortia to convert plastic waste into higher-value products.
BIOPLASTECH LTD
Irish biotech SME engineering bacteria to break down and upcycle plastic waste into biobased materials and sustainable packaging.
Their core work
Bioplastech is a Dublin-based SME specializing in microbial biotechnology for plastics — specifically using engineered bacteria (notably Pseudomonas putida) to break down and upcycle plastic waste into valuable biobased materials like polyhydroxyalkanoates (PHA). They bring synthetic biology and metabolic engineering expertise to EU consortia tackling the plastic crisis, contributing to the biological depolymerisation of mixed plastics and the design of sustainable food packaging alternatives. Their core value is translating microbial engineering into industrially relevant plastic recycling and bioplastic production processes.
What they specialise in
All four projects (P4SB, SinFonia, MIX-UP, UPLIFT) involve synthetic biology or metabolic engineering as a core method.
MIX-UP and UPLIFT focus on polyhydroxyalkanoate production and sustainable polymer alternatives for packaging.
MIX-UP and UPLIFT address enzyme-based breakdown of mixed plastics and eco-design of recyclable polymers.
SinFonia (their largest funded project at EUR 965K) focuses on engineering Pseudomonas putida for biological fluorination of compounds.
How they've shifted over time
Bioplastech started with a tight focus on Pseudomonas putida synthetic biology — their earliest projects (P4SB, SinFonia) were fundamentally about engineering this single organism for plastic valorisation and biofluorination. From 2020 onward, their scope broadened significantly: they moved into mixed microbial consortia, enzymatic depolymerisation, eco-design principles, and food packaging applications. The trajectory shows a clear shift from fundamental microbial engineering toward applied circular economy solutions for the plastics industry.
Bioplastech is moving from lab-scale microbial engineering toward industry-ready plastic recycling and sustainable packaging solutions, positioning themselves at the intersection of biotechnology and circular economy.
How they like to work
Bioplastech operates exclusively as a consortium participant, never as coordinator — consistent with their profile as a specialist SME contributing deep technical expertise rather than managing large projects. With 41 unique partners across 17 countries in just 4 projects, they work in large, diverse consortia (averaging ~10 partners per project). This suggests they are a sought-after specialist that larger groups recruit for their specific microbial engineering capabilities.
Despite being a small company with only 4 projects, Bioplastech has built a remarkably wide network of 41 partners spanning 17 countries — nearly half of all EU member states. Their connections are heavily concentrated in the industrial biotechnology and environmental research communities across Western and Northern Europe.
What sets them apart
Bioplastech occupies a rare niche: an SME with deep, hands-on expertise in engineering Pseudomonas putida for industrial plastic biotransformation. While many academic labs work on microbial plastic degradation, few private companies can bring this specific organism-level engineering capability to a consortium. For anyone building a project around biological plastic recycling or biobased polymer production, Bioplastech offers a commercial partner with a proven track record in exactly this space.
Highlights from their portfolio
- SinFoniaTheir largest single grant (EUR 965K) and a unique application — engineering Pseudomonas putida for biofluorination, extending their microbial platform beyond plastics.
- MIX-UPTackles the hard problem of mixed plastics biodegradation using microbial communities, directly addressing one of the biggest gaps in current recycling infrastructure.
- UPLIFTTheir most recent and most applied project, targeting sustainable food and drink packaging — the closest to a market-ready application in their portfolio.